¿Qué es el Rituximab? Indicaciones, mecanismo de acción y riesgos clave

What is rituximab and why has it revolutionized the treatment of autoimmune and hematological diseases? In this FAPsGal Training video, we analyze the mechanism of action of rituximab (anti-CD20), its main clinical indications, safety risks, monitoring, and key aspects for its safe use in rheumatoid arthritis, vasculitis, lupus, Sjögren's syndrome, and other immune-mediated diseases. Video Content ✔ What is CD20 and how does rituximab work? ✔ Key approved indications ✔ Rheumatoid arthritis ✔ ANCA-associated vasculitis ✔ Systemic lupus erythematosus ✔ Sjögren's syndrome ✔ Premedication and administration ✔ Risk of opportunistic infections ✔ Hepatitis B reactivation ✔ Clinical and laboratory monitoring ✔ Safety of biologic therapies PART OF THE BIOLOGICAL THERAPIES CLUSTER ▶ JAK inhibitors: what they are and what risks to monitor ▶ Tocilizumab and Sarilumab (IL-6) ▶ Interleukin-1: key differences ▶ Anti-TNF in Crohn's disease More clinical training: https://fapsgal.org Subscribe for Content on biologic therapies, advanced pharmacotherapy, immune-mediated diseases, and treatment optimization. ▶ Before starting a biologic: vaccines and infections ▶ Systemic lupus: current treatment ▶ Methotrexate: correct dosage and safe use #Rituximab #BiologicTherapies #ClinicalPharmacy